{"id":"W2019925885","doi":"10.1016/j.clcc.2013.12.002","title":"Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147","year":2014,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"FOLFIRI; Medicine; Cetuximab; Irinotecan; KRAS; Colorectal cancer; Internal medicine; Oncology; FOLFOX; Clinical endpoint; Hazard ratio; Randomized controlled trial; Cancer; Surgery; Oxaliplatin; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001740549,0.001504085,0.003130019,0.000419843,0.0004655699,0.001239203,0.0007984495,0.001615869,0.004611752],"category_scores_gemma":[0.001784641,0.0005580293,0.003311203,0.0004548472,0.001079128,0.001399153,0.0005390766,0.003117636,0.000889487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00136458,"about_ca_system_score_gemma":0.001372788,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002397175,"about_ca_topic_score_gemma":0.007940394,"domain_scores_codex":[0.9992125,0.000442351,0.0000459427,0.0001393882,0.00004336448,0.0001164134],"domain_scores_gemma":[0.9993346,0.0001891043,0.0001436188,0.00007147979,0.00004392953,0.000217086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9857648,0.001093778,0.0007248114,0.0003697854,0.001334808,0.00002056652,0.0000298274,0.0003564238,0.001002558,0.00008918977,0.0005232978,0.008690081],"study_design_scores_gemma":[0.8760561,0.1103783,0.007108431,0.0001359646,0.00311092,0.0000687436,0.00007417313,0.0007102482,0.0005824213,0.0003193108,0.001421871,0.00003356753],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819865,0.009834301,0.0004810095,0.00123212,0.0008492206,0.0008540082,0.001012813,0.00007137272,0.003678628],"genre_scores_gemma":[0.9891802,0.0028531,0.0006095705,0.0009093719,0.0004123054,0.0005574394,0.001725023,0.00002723804,0.003725855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004611752,"threshold_uncertainty_score":0.01542789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06875470791630059,"score_gpt":0.4297178547705361,"score_spread":0.3609631468542355,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}